SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-049561
Filing Date
2005-03-14
Accepted
2005-03-14 16:53:04
Documents
3
Period of Report
2005-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 22449
2 FORM OF RESTRICTED STOCK AWARD AGREEMENT FOR EXECUTIVE OFFICERS (FORM A) dex101.htm EX-10.1 17642
3 PRESS RELEASE DATED MARCH 8, 2005 dex991.htm EX-99.1 9337
  Complete submission text file 0001193125-05-049561.txt   51480
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 05678936
SIC: 2834 Pharmaceutical Preparations